Paper 71 - SECOND MALIGNANT NEOPLASM FOLLOWING TREATMENT FOR NON-METASTATIC EWING SARCOMA IN PATIENTS ENROLLED ON FRONTLINE PHASE 3 CLINICAL TRIALS: A REPORT FROM CHILDREN'S ONCOLOGY GROUP

Author(s)

• 

  Susan Whiteway, MD

  Associate Professor
  Department of Pediatrics, Uniformed Services University
  Potomac, Maryland, United States

  Slides

Co-Author(s)

• ND

  Natalie DelRocco, PhD

  Childrens Oncology Group
  Los Angeles, California, United States
• RH

  Ruxu Han, MS

  Childrens Oncology Group
  Monrovia, California, United States
• HG

  Holcombe Grier, MD

  Dana-Farber/Boston Children's Cancer and Blood Disorders Center,
  Boston, Massachusetts, United States
• PL

  Patrick Leavey, MD

  UT Southwestern/Simmons Cancer Center-Dallas
  Dallas, Texas, United States
• DR

  Damon Reed, MD

  Memorial Sloan Kettering
  New York, New York, United States
• KJ

  Katherine A. Janeway, MD MMSc

  Senior Physician
  Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School
  Boston, Massachusetts, United States
• MK

  Mark Krailo, PhD

  Childrens Oncology Group
  Monrovia, California, United States
• SB

  Smita Bhatia, MD/MPH

  Children's Hospital of Alabama
  Birmingham, Alabama, United States
• LM

  Leo Mascarenhas, MD, MS

  Cedars-Sinai Medical Center, California, CA, USA
  California, California, United States